On August 31, 2010, the Board of Directors of First China Pharmaceutical Group, Inc. (the “Company”) appointed Mr. Gregory D. Tse to the Board of Directors of the Company. Mr. Tse, age 51, has over 25 years of international finance, marketing, media, PR and advertising experience with an extensive brand management track record in North America, Hong Kong and China. In China, Mr. Tse has helped many international brands to enter into the marketplace before moving on to become one of China’s first communications/media M&A specialists. Mr. Tse most recently served as Head of China Advisory for Calneva Financial Group from July 2004 to the present date.
2443 Alder Street, Vancouver, British Columbia Canada, V6H 4A4
The principals of CFG Ltd. source out credible business opportunities in China, complete the due diligence on the project, assist in arranging financing for these enterprises and then guide the private company through the legal and auditing processes required to qualify them for a listing on a recognized stock exchange in the United States. CFG Ltd. has relationships with Certified Public Accounting firms and legal firms (both in China and North America) to ensure that the "going public" process goes smoothly and in compliance with all rules and regulations of the governing stock exchanges in the U.S.